[HTML][HTML] Advanced Hydrogel systems for mandibular reconstruction

J Guo, H Yao, X Li, L Chang, Z Wang, W Zhu, Y Su… - Bioactive materials, 2023 - Elsevier
Mandibular defect becomes a prevalent maxillofacial disease resulting in mandibular
dysfunctions and huge psychological burdens to the patients. Considering the routine …

[HTML][HTML] Hydrogels for oral tissue engineering: challenges and opportunities

A Chen, S Deng, J Lai, J Li, W Chen, SN Varma… - Molecules, 2023 - mdpi.com
Oral health is crucial to daily life, yet many people worldwide suffer from oral diseases. With
the development of oral tissue engineering, there is a growing demand for dental …

[HTML][HTML] Research progress of 3D printed poly (ether ether ketone) in the reconstruction of craniomaxillofacial bone defects

Q Su, Y Qiao, Y Xiao, S Yang, H Wu, J Li… - … in Bioengineering and …, 2023 - frontiersin.org
The clinical challenge of bone defects in the craniomaxillofacial region, which can lead to
significant physiological dysfunction and psychological distress, persists due to the complex …

[HTML][HTML] Osteosarcoma of the jaws: An overview of the pathophysiological mechanisms

H Bertin, A Gomez-Brouchet, F Rédini - Critical Reviews in Oncology …, 2020 - Elsevier
Osteosarcoma (OS) is the most common cancer of bone. Jaw osteosarcoma (JOS) is rare
and it differs from long-bone OS (LBOS) in terms of the time of onset (two decades later) …

In vitro biological evaluation of epigallocatechin gallate (EGCG) release from three-dimensional printed (3DP) calcium phosphate bone scaffolds

Y Jo, N Sarkar, S Bose - Journal of Materials Chemistry B, 2023 - pubs.rsc.org
Three-dimensional printed (3DP) tricalcium phosphate (TCP) scaffolds can guide bone
regeneration, especially for patient-specific defect repair applications in low-load bearing …

Does neoadjuvant chemotherapy provide a survival benefit in maxillofacial osteosarcoma: a systematic review and pooled analysis

D Khadembaschi, M Jafri, P Praveen, S Parmar… - Oral Oncology, 2022 - Elsevier
Maxillofacial osteosarcoma (MFOS) is a rare disease that presents and behaves differently
to the more commonly seen osteosarcoma (OS) of long bones. Neoadjuvant chemotherapy …

Osteosarcomas of the jaws differ from their peripheral counterparts and require a distinct treatment approach. Experiences from the DOESAK Registry

D Baumhoer, P Brunner, S Eppenberger-Castori… - Oral oncology, 2014 - Elsevier
Objective We aim to emphasize crucial differences between osteosarcomas of the jaws
(OSj) and those of the peripheral skeleton (OSp) and to question current therapeutic …

Osteosarcoma in pediatric patients and young adults: a single institution retrospective review of presentation, therapy, and outcome

CL Haddox, G Han, L Anijar, O Binitie, GD Letson… - Sarcoma, 2014 - Wiley Online Library
Background. Little is known about how cumulative chemotherapy delivery influences the
poorer outcome observed in young adult (YA, 18–40 years) versus pediatric (< 18 years) …

[HTML][HTML] Osteosarcomas of the mandible: multidisciplinary management of a rare tumor of the young adult a cooperative study of the GSF-GETO, Rare Cancer Network …

J Thariat, T Schouman, A Brouchet, J Sarini, RC Miller… - Annals of oncology, 2013 - Elsevier
Background Mandibular osteosarcomas (MOS) mostly affect young adults. Their treatment is
extrapolated from that of extragnathic osteosarcomas. Material and methods A retrospective …

Management of osteosarcoma of the head and neck

A Pai, M Mair - Current Opinion in Otolaryngology & Head and …, 2023 - journals.lww.com
Management of osteosarcoma of the head and neck : Current Opinion in Otolaryngology &
Head and Neck Surgery Management of osteosarcoma of the head and neck : Current Opinion …